Byron Kneller, VP, Process Development, Seattle and Luca Alberici, General Manager, Milan, present AGC Biologics’ end-to-end CDMO protein expression and cell and gene therapy manufacturing capabilities at BIO-Europe in October, 2020.
Video: BIO-Europe 2020 Presentation: AGC Biologics' Capabilities and Introduction to Cell and Gene Therapy
by David Self Events, Thought Leadership, Cell & Gene Therapy
Learn More
Article: Process Development: How to Win the Race in Cell & Gene Therapy
by David Self Published on 10/6/20 11:24 AM Thought Leadership, Cell & Gene Therapy
In this spotlight article, presented by BioInsights, Dr. Ramin Baghirzade, AGC Biologics' Global Head of Business Development for Cell & Gene Therapy, shares his expert insights on the state of the industry, and four inter-connected variables exerting pressure on therapeutics developers to improve their processes earlier in the product’s development.
Follow Us
